Highline Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Highline Wealth Partners's ABBV Position: Q2 2026 in Review
Highline Wealth Partners increased its AbbVie (ABBV) stake by 21% in Q2 2026, buying an estimated $15.5K and bringing the position to 419 shares worth $106K. The position accounts for 0.02% of the portfolio, ranked #161.
Highline Wealth Partners first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Highline Wealth Partners held 419 shares of AbbVie worth $106K as of Q2 2026.
- Highline Wealth Partners bought 72 AbbVie shares in Q2 2026, an estimated $15.5K.
- AbbVie made up 0.02% of Highline Wealth Partners's portfolio in Q2 2026, its #161 holding.
- Highline Wealth Partners first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.